Sian Faustini

University of Birmingham - Institute of Cancer and Genomic Sciences

Birmingham

United Kingdom

University of Birmingham - Clinical Immunology Service

United Kingdom

SCHOLARLY PAPERS

10

DOWNLOADS
Rank 9,671

SSRN RANKINGS

Top 9,671

in Total Papers Downloads

7,033

SSRN CITATIONS

4

CROSSREF CITATIONS

0

Scholarly Papers (10)

1.

Single Vaccination with BNT162b2 or ChAdOx1 in Older People Induces Equivalent Antibody Generation but Enhanced Cellular Responses after ChAdOx1

Number of pages: 15 Posted: 13 Apr 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University Hospitals Birmingham NHS Foundation Trust, Harborne Medical Practice, Public Health England, Public Health England - Immunisation and Countermeasures Division, Public Health England - National Infection Service, University of Birmingham - Institute of Cancer and Genomic Sciences and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 4,395 (3,101)
Citation 10

Abstract:

Loading...

Vaccination, SARS-CoV-2, COVID, Antibody, Cellular, mRNA, ChAdOx1

2.

BNT162b2 Vaccination in People Over 80 Years of Age Induces Strong Humoral Immune Responses with Cross Neutralisation of P.1 Brazilian Variant

Number of pages: 24 Posted: 31 Mar 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, Quinton and Harborne PCN, University of Birmingham - Institute of Immunology and Immunotherapy, Deparment of Buisness Energy and Industrial Strategy - Vaccine Taskforce, Public Health England, Public Health England - Immunisation and Countermeasures Division, Public Health England - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Public Health England, UK Health Security Agency, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Public Health England - National Infection Service, Oxford Immunotec LTD, University of Birmingham - Institute of Cancer and Genomic Sciences and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 1,220 (24,246)

Abstract:

Loading...

Vaccination. SARS-CoV-2. COVID. Immunosenescence. Antibody. T-cell. Variant. Neutralisation. Ageing. Immunisation

3.

Antibody Responses After First and Second COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukaemia

Number of pages: 23 Posted: 25 May 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Applied Health Research, UK Health Security Agency, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, Leeds Teaching Hospitals NHS Trust - St. James’s University Hospital, University Hospitals Birmingham - Queen Elizabeth Hospital, University Hospitals Birmingham - Birmingham Heartlands Hospital, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 957 (34,320)
Citation 3

Abstract:

Loading...

Vaccination; CLL; Leukaemia; SARS-CoV-2; COVID; Antibody

4.

Sustained T Cell Immunity, Protection and Boosting Using Extended Dosing Intervals of BNT162b2 mRNA Vaccine

Number of pages: 93 Posted: 21 Jul 2021
Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Oxford University Hospitals NHS Foundation TrustUniversity of Oxford - Nuffield Department of Clinical Neurosciences, University of Oxford - Wellcome Centre for Human Genetics, University of Oxford - Peter Medawar Building for Pathogen Research, Sheffield Teaching Hospitals NHS Foundation Trust, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Cancer and Genomic Science, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, Public Health England Colindale, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Wellcome Centre for Human Genetics, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Sheffield Teaching Hospitals NHS Foundation Trust, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford, University Hospitals Birmingham NHS Foundation Trust, Public Health England Colindale, Public Health England Colindale, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Peter Medawar Building for Pathogen Research, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, Oxford University Hospitals NHS Foundation Trust, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Peter Medawar Building for Pathogen Research, Sheffield Teaching Hospitals NHS Foundation Trust, University of Oxford - Wellcome Trust Centre for Human Genetics, Oxford University Hospitals NHS Foundation Trust, University of Oxford - NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance, Public Health England Colindale, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Oxford - Wellcome Centre for Human Genetics, University of Oxford - Wellcome Centre for Human Genetics, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research and Independent
Downloads 157 (260,819)
Citation 6

Abstract:

Loading...

5.

Impaired Neutralisation of SARS-CoV-2 Delta Variant in Vaccinated Patients With B Cell Chronic Lymphocytic Leukaemia

Number of pages: 26 Posted: 12 Oct 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham, University of Glasgow, University of Glasgow - Centre for Virus Research (CVR), University of Glasgow, University of Glasgow - Centre for Virus Research (CVR), University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham, UK Health Security Agency, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Cancer and Genomic Sciences, Government of the United Kingdom - Royal Wolverhampton NHS Trust, Barking, Havering and Redbridge University Hospitals NHS Trust - Sandwell and West Birmingham Hospitals NHS Trust, Herefordshire and Worcestershire Health and Care NHS Trust, Government of the United Kingdom - University Hospitals Birmingham, University Hospitals Birmingham - Birmingham Heartlands Hospital and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 151 (269,077)

Abstract:

Loading...

CLL, COVID-19, SARS-CoV-2, Vaccination

6.

Longitudinal Protection Following Natural SARS-CoV-2 Infection and Early Vaccine Responses: Insights from a Cohort of Community Based Dental Health Care Professionals

Number of pages: 15 Posted: 15 Feb 2021
University of Birmingham - Clinical Immunology Service, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Clinical Sciences, The Binding Site Group Ltd., University of Birmingham - Clinical Immunology Service, University of Birmingham - Clinical Immunology Service, University of Birmingham - Clinical Immunology Service, University of Birmingham - Clinical Immunology Service, Birmingham Local Dental Committee, Birmingham Community Healthcare Trust, Birmingham Community Healthcare Trust, Birmingham Community Healthcare Trust, Birmingham Community Healthcare Trust, Birmingham Community Healthcare Trust, Birmingham Community Healthcare Trust, University of Birmingham - Clinical Immunology Service, University of Birmingham - Institute of Cancer and Genomic Sciences, Birmingham Community Healthcare Trust and Birmingham Community Healthcare Trust
Downloads 59 (488,103)

Abstract:

Loading...

Dentistry, SARS-CoV-2. COVID-19, vaccination, antibodies

7.

Determinants of Antibody Responses to Two Doses of ChAdOx1 nCoV-19 or Bnt162b2 and a Subsequent Booster Dose of BNT162b2 or mRNA-1273: Population-Based Cohort Study (COVIDENCE UK)

Number of pages: 36 Posted: 03 Mar 2022
Queen Mary University of London, University of Birmingham - Institute of Cancer and Genomic Sciences, Queen Mary University of London - Institute of Population Health Sciences, Queen Mary University of London, Queen Mary University of London, Queen Mary University of London - Institute of Population Health Sciences, Queen Mary University of London, Queen Mary University of London, Queen Mary University of London, Jane Symons Media, Swansea University - Swansea University Medical School, Swansea University - Population Data Science, Queen Mary University of London - Institute of Population Health Sciences, Queen's University Belfast, University of Edinburgh - Asthma UK Centre for Applied Research, Queen Mary University of London - Institute of Population Health Sciences, University of Birmingham - Institute of Cancer and Genomic Sciences and Queen Mary University of London - Barts and The London School of Medicine and Dentistry
Downloads 43 (558,440)

Abstract:

Loading...

SARS-CoV-2 vaccine, ChAdOx1, BNT162b2, mRNA-1273, antibody, ethnicity, obesity, vitamin D

8.

Determinants of Pre-Vaccination Antibody Responses to SARS-CoV-2: A Population-Based Longitudinal Study (COVIDENCE UK)

Number of pages: 31 Posted: 18 Oct 2021
Queen Mary University of London - Institute of Population Health Sciences, University of Birmingham - Institute of Cancer and Genomic Sciences, Queen Mary University of London - Institute of Population Health Sciences, Queen Mary University of London, Queen Mary University of London, Queen Mary University of London, Queen Mary University of London, Queen Mary University of London, Jane Symons Media, Swansea University - Swansea University Medical School, Swansea University - Population Data Science, Queen Mary University of London - Institute of Population Health Sciences, Queen's University Belfast, University of Edinburgh - Asthma UK Centre for Applied Research, University of Birmingham - Institute of Cancer and Genomic Sciences, Queen Mary University of London - Institute of Population Health Sciences and Queen Mary University of London - Barts and The London School of Medicine and Dentistry
Downloads 32 (618,581)

Abstract:

Loading...

SARS-CoV-2, anti-S IgG IgA IgM, alcohol, physical exercise, ethnicity, obesity, travel, occupation

The Innate and Adaptive Immune Landscape of SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children (MIS-C) from Acute Disease to Recovery

Number of pages: 48 Posted: 16 Apr 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Limerick - Health Research Institute and the Bernal Institute, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Warwick - Division of Biomedical Sciences, University of Warwick - Bioinformatics Research Technology Platform, University of Warwick - Division of Biomedical Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, Birmingham Women’s and Children’s NHS Foundation Trust, Government of the United Kingdom - Birmingham Women’s and Children’s NHS Foundation Trust, Government of the United Kingdom - Birmingham Women’s and Children’s NHS Foundation Trust, University Hospitals Birmingham NHS Foundation Trust, Government of the United Kingdom - Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham Women’s and Children’s NHS Foundation Trust - Paediatric Intensive Care Unit, Government of the United Kingdom - Birmingham Women’s and Children’s NHS Foundation Trust, Government of the United Kingdom - Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham Women’s and Children’s NHS Foundation Trust - Paediatric Intensive Care Unit, University Hospitals Birmingham NHS Foundation Trust - Heartlands Hospital, University of Birmingham, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - NIHR Birmingham Biomedical Research Centre and Institute of Cancer and Genomic Sciences and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 7 (854,183)

Abstract:

Loading...

The Innate and Adaptive Immune Landscape of SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children (MIS-C) From Acute Disease to Recovery

Number of pages: 55 Posted: 19 Jul 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Limerick - Health Research Institute and the Bernal Institute, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Warwick - Division of Biomedical Sciences, University of Warwick - Bioinformatics Research Technology Platform, University of Warwick - Division of Biomedical Sciences, University of Limerick - Health Research Institute and the Bernal Institute, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham Women’s and Children’s NHS Foundation Trust, University Hospitals Birmingham NHS Foundation Trust - Heartlands Hospital, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham Women’s and Children’s NHS Foundation Trust - Paediatric Intensive Care Unit, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham Women’s and Children’s NHS Foundation Trust, University Hospitals Birmingham NHS Foundation Trust - Heartlands Hospital, University of Birmingham - Clinical Immunology Service, University of Birmingham - Institute of Cancer and Genomic Sciences, Cardiff University - Systems Immunity Research Institute, Cardiff University - Systems Immunity Research Institute, University of Birmingham - NIHR Birmingham Biomedical Research Centre and Institute of Cancer and Genomic Sciences and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 6 (865,407)

Abstract:

Loading...

10.

Evolution of Long-Term Hybrid Immunity in Healthcare Workers after Different Covid-19 Vaccination Regimens: A Longitudinal Observational Cohort Study

Number of pages: 56 Posted: 08 Aug 2022
University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Wellcome Trust Centre for Human Genetics, affiliation not provided to SSRN, Sheffield Teaching Hospitals NHS Foundation Trust, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Cancer and Genomic Science, affiliation not provided to SSRN, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, affiliation not provided to SSRN, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Wellcome Trust Centre for Human Genetics, affiliation not provided to SSRN, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, affiliation not provided to SSRN, Dept Infection, Immunity & Cardiovascular Disease, University of Sheffield, affiliation not provided to SSRN, 5. Dept of Infectious Diseases & Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, affiliation not provided to SSRN, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford, affiliation not provided to SSRN, University of Cambridge - MRC Toxicology Unit, University of Cambridge - MRC Toxicology Unit, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, University of Oxford - Wellcome Trust Centre for Human Genetics, Oxford University Hospitals NHS Foundation Trust, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Peter Medawar Building for Pathogen Research, affiliation not provided to SSRN, University of Oxford - Wellcome Centre for Human Genetics, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Cambridge - MRC Toxicology Unit, University of Oxford - Wellcome Centre for Human Genetics, University of Oxford, University of Oxford - NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance, Public Health England Colindale, Newcastle University, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Oxford, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Oxford - Nuffield Department of Clinical Medicine, University of Oxford - Peter Medawar Building for Pathogen Research, University of Liverpool - NIHR Health Protection Research Unit for Emerging and Zoonotic Infection and Independent
Downloads 6

Abstract:

Loading...

SARS-CoV-2, COVID-19, COVID vaccine, T cells, antibody, immunity